IPA
Price
$0.38
Change
-$0.01 (-2.56%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
17.29M
KURA
Price
$7.24
Change
-$0.29 (-3.85%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
584.67M
51 days until earnings call
Ad is loading...

IPA vs KURA

Header iconIPA vs KURA Comparison
Open Charts IPA vs KURABanner chart's image
ImmunoPrecise Antibodies
Price$0.38
Change-$0.01 (-2.56%)
Volume$13.64K
Capitalization17.29M
Kura Oncology
Price$7.24
Change-$0.29 (-3.85%)
Volume$30.89K
Capitalization584.67M
IPA vs KURA Comparison Chart
Loading...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPA vs. KURA commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPA is a Hold and KURA is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (IPA: $0.35 vs. KURA: $7.33)
Brand notoriety: IPA and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPA: 15% vs. KURA: 99%
Market capitalization -- IPA: $17.29M vs. KURA: $584.67M
IPA [@Biotechnology] is valued at $17.29M. KURA’s [@Biotechnology] market capitalization is $584.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPA’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • IPA’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, both IPA and KURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPA’s TA Score shows that 3 TA indicator(s) are bullish while KURA’s TA Score has 5 bullish TA indicator(s).

  • IPA’s TA Score: 3 bullish, 4 bearish.
  • KURA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, KURA is a better buy in the short-term than IPA.

Price Growth

IPA (@Biotechnology) experienced а -5.19% price change this week, while KURA (@Biotechnology) price change was -6.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

KURA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($585M) has a higher market cap than IPA($17.3M). IPA YTD gains are higher at: -14.355 vs. KURA (-15.844). IPA has higher annual earnings (EBITDA): -24.28M vs. KURA (-195.08M). KURA has more cash in the bank: 455M vs. IPA (3.53M). IPA (16.4M) and KURA (16.6M) have identical debt. IPA has higher revenues than KURA: IPA (24.1M) vs KURA (0).
IPAKURAIPA / KURA
Capitalization17.3M585M3%
EBITDA-24.28M-195.08M12%
Gain YTD-14.355-15.84491%
P/E RatioN/AN/A-
Revenue24.1M0-
Total Cash3.53M455M1%
Total Debt16.4M16.6M99%
FUNDAMENTALS RATINGS
IPA vs KURA: Fundamental Ratings
IPA
KURA
OUTLOOK RATING
1..100
5010
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9291
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
6n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPA's Valuation (17) in the null industry is in the same range as KURA (31) in the Biotechnology industry. This means that IPA’s stock grew similarly to KURA’s over the last 12 months.

IPA's Profit vs Risk Rating (100) in the null industry is in the same range as KURA (100) in the Biotechnology industry. This means that IPA’s stock grew similarly to KURA’s over the last 12 months.

IPA's SMR Rating (100) in the null industry is in the same range as KURA (100) in the Biotechnology industry. This means that IPA’s stock grew similarly to KURA’s over the last 12 months.

KURA's Price Growth Rating (91) in the Biotechnology industry is in the same range as IPA (92) in the null industry. This means that KURA’s stock grew similarly to IPA’s over the last 12 months.

KURA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as IPA (100) in the null industry. This means that KURA’s stock grew similarly to IPA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IPAKURA
RSI
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
73%
Bullish Trend 7 days ago
75%
Momentum
ODDS (%)
N/A
Bearish Trend 7 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
83%
Advances
ODDS (%)
Bullish Trend about 1 month ago
81%
Bullish Trend about 1 month ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
N/A
Bullish Trend 7 days ago
81%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
86%
View a ticker or compare two or three
Ad is loading...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

IPA and

Correlation & Price change

A.I.dvisor tells us that IPA and ITRM have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPA and ITRM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPA
1D Price
Change %
IPA100%
+7.11%
ITRM - IPA
26%
Poorly correlated
+1.50%
TPST - IPA
25%
Poorly correlated
-0.14%
IBO - IPA
23%
Poorly correlated
N/A
AFMD - IPA
22%
Poorly correlated
-2.06%
CING - IPA
21%
Poorly correlated
-2.53%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with OPORF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then OPORF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
+1.10%
OPORF - KURA
62%
Loosely correlated
N/A
PYXS - KURA
60%
Loosely correlated
+2.70%
ZYME - KURA
42%
Loosely correlated
+0.08%
FATE - KURA
38%
Loosely correlated
-7.77%
EVAX - KURA
34%
Loosely correlated
-1.06%
More